Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Uber
UBER
|
+$551M |
| 3 |
Expedia Group
EXPE
|
+$523M |
| 4 |
PayPal
PYPL
|
+$452M |
| 5 |
Eaton
ETN
|
+$408M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$681M |
| 2 |
RTN
Raytheon Company
RTN
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$537M |
| 4 |
Charter Communications
CHTR
|
+$472M |
| 5 |
SPDR Gold Trust
GLD
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.14% |
| 2 | Financials | 4.52% |
| 3 | Industrials | 4.17% |
| 4 | Healthcare | 3.91% |
| 5 | Consumer Discretionary | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$154M
| $46.7M | 0.02% |
48,281
+10,483
| +28% | +$12.7M |
|
777
CALL
DuPont de Nemours
DD
$19.3B
| $46.7M | 0.02% |
578,938
+28,521
| +5% | +$2.37M |
|
778
Zurn Elkay Water Solutions
ZWS
$8.82B
| $46.6M | 0.02% |
2,964,032
+1,145,676
| +63% | +$16.5M |
|
779
American Express
AXP
$234B
| $46.4M | 0.02% |
372,613
-81,779
| -18% | -$9.77M |
|
780
CALL
CME Group
CME
$94.4B
| $46.3M | 0.02% |
230,500
-60,900
| -21% | -$12.5M |
|
781
PUT
Seagate
STX
$192B
| $46.2M | 0.02% |
775,900
-153,300
| -16% | -$8.81M |
|
782
Woodward
WWD
$22.1B
| $46.2M | 0.02% |
389,741
-235,209
| -38% | -$26.5M |
|
783
PUT
General Dynamics
GD
$104B
| $46.1M | 0.02% |
261,300
-3,300
| -1% | -$592K |
|
|
HES
784
CALL
DELISTED
Hess
HES
| $46.1M | 0.02% |
689,500
+234,900
| +52% | +$15.4M |
|
785
Ascendis Pharma A/S
ASND
$16B
| $45.9M | 0.02% |
329,682
+320,970
| +3,684% | +$35.7M |
|
786
Saic
SAIC
$5.09B
| $45.8M | 0.02% |
526,361
-310,695
| -37% | -$26M |
|
787
PUT
Arista Networks
ANET
$240B
| $45.7M | 0.02% |
3,596,800
-444,800
| -11% | -$5.85M |
|
788
Conagra Brands
CAG
$7.18B
| $45.7M | 0.02% |
1,333,696
+915,675
| +219% | +$26.5M |
|
789
Neurocrine Biosciences
NBIX
$16.9B
| $45.6M | 0.02% |
424,155
+243,978
| +135% | +$25.5M |
|
790
Cenovus Energy
CVE
$53B
| $45.5M | 0.02% |
4,479,356
-4,438,298
| -50% | -$40.3M |
|
791
Target
TGT
$67.3B
| $45.5M | 0.02% |
354,985
-203,737
| -36% | -$23.9M |
|
792
RingCentral
RNG
$5.09B
| $45.4M | 0.02% |
269,406
+16,150
| +6% | +$2.66M |
|
793
KLA
KLAC
$255B
| $45.4M | 0.02% |
2,546,170
-3,012,280
| -54% | -$50.5M |
|
794
International Flavors & Fragrances
IFF
$20.7B
| $45.4M | 0.02% |
351,554
+102,472
| +41% | +$13.1M |
|
795
Methanex
MEOH
$4.14B
| $45.2M | 0.02% |
1,171,284
+127,381
| +12% | +$4.78M |
|
796
W.P. Carey
WPC
$16.5B
| $45.2M | 0.02% |
576,383
+440,345
| +324% | +$36.9M |
|
797
CALL
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$936M
| $45M | 0.02% |
258,520
-106,180
| -29% | -$15.3M |
|
|
K
798
PUT
DELISTED
Kellanova
K
| $44.9M | 0.02% |
692,144
+72,420
| +12% | +$4.39M |
|
|
DRNA
799
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $44.9M | 0.02% |
2,039,923
+108,455
| +6% | +$2.18M |
|
800
NextCure
NXTC
$23.5M
| $44.9M | 0.02% |
66,476
-11,987
| -15% | -$6.01M |
|
Similar funds
Citadel Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, Citadel Advisors held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors withdrew a net $8.18B in Q4 2019, closing 1,267 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.3% a quarter earlier, followed by Financials and Industrials.
Against the trend, Citadel Advisors opened a new position in Interxion Holding N.V. worth $83.9M.
- Citadel Advisors's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
- Citadel Advisors added most to Amazon in Q4 2019, an estimated $615M increase.
- Citadel Advisors's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
- Citadel Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
- Citadel Advisors's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
- Citadel Advisors opened 1,220 new positions and closed 1,267 in Q4 2019.
- Citadel Advisors's portfolio value rose 8.7% quarter-over-quarter to $230B.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.